The need for education in pharmacogenomics: a regulatory perspective

被引:21
作者
Frueh, FW [1 ]
Goodsaid, F [1 ]
Rudman, A [1 ]
Huang, SM [1 ]
Lesko, LJ [1 ]
机构
[1] US FDA, Ctr Drug Evaluat & Res, Off Clin Pharmacol & Biopharmaceut, Rockville, MD 20852 USA
关键词
D O I
10.1038/sj.tpj.6500316
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
引用
收藏
页码:218 / 220
页数:3
相关论文
共 3 条
[1]   From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community [J].
Frueh, FW ;
Gurwitz, D .
PHARMACOGENOMICS, 2004, 5 (05) :571-579
[2]   Pharmacogenomic-guided drug development: Regulatory perspective [J].
Lesko L.J. ;
Woodcock J. .
The Pharmacogenomics Journal, 2002, 2 (1) :20-24
[3]   Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective [J].
Lesko, LJ ;
Woodcock, J .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (09) :763-769